Latest News

Common multiple sclerosis drugs taken together do not reduce relapse risk

A recent clinical trial found that interferonβ-1a (INF) and glatiramer acetate (GA), two of the most commonly prescribed drugs for multiple sclerosis (MS), provide no additional clinical benefit when taken together. While findings suggest that taking both INF and GA together was not superior to GA monotherapy in reducing relapse risk; the combination therapy does appear to reduce new lesion activity and total lesion volume.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Risks of opioids outweigh benefits for headache, low back pain, other conditions

  • Low social support linked to poor health in young heart attack survivors

  • EEG's potential to reveal depolarizations following TBI

  • To improve oral health of adults with developmental disabilities, improve support for caregivers

  • Gene interacts with stress, leads to heart disease in some people

  • Omega-3 fatty acids may prevent some forms of depression

  • Power can corrupt even the honest

  • Keeping your eyes on the prize can help with exercise, study finds

  • Predicting future course of psychotic illness

  • Insight into challenges facing college athletes

  •